What is Leerink Partnrs’ Estimate for BBIO Q1 Earnings?
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Leerink Partnrs issued their Q1 2025 earnings estimates for shares of BridgeBio Pharma in a research note issued on Monday, February 24th. Leerink Partnrs analyst M. Foroohar anticipates that the company will post earnings of ($0.73) per share for the quarter. The consensus estimate for BridgeBio Pharma’s […]
